Skeletal muscle atrophy is a debilitating response to weightlessness or disuse, starvation and many systemic diseases, including diabetes, cancer and renal failure. We had proposed that a common set of transcriptional adaptations underlie the loss of muscle mass in these different states. To test this hypothesis, we have used cDNA microarrays to compare the changes in content of specific mRNAs in muscles atrophying due to different causes. We compared muscles from fasted mice, from rats with cancer cachexia, streptozotocin-induced diabetes mellitus, and uremia induced by subtotal nephrectomy and from pair-fed control rats. Although content of more than 90% of mRNAs did not change including those for the myofibrillar apparatus, we found a common set of genes, termed 'atrogenes', that were induced or suppressed in muscles in these four catabolic states. Among the strongly induced genes were many involved in protein degradation, including polyubiquitins, Ub fusion proteins, the Ub ligases atrogin-1/MAFbx and MuRF-1, multiple but not all subunits of the 20S proteasome and its 19S regulator and cathepsin L. Many genes required for ATP production and late steps in glycolysis were down-regulated, as were many transcripts for extracellular matrix proteins. A number of genes not previously implicated in muscle atrophy were dramatically up-regulated (lipin, metallothionein, AMP deaminase, RNA helicase related protein, TG-interacting factor) and several growth-related mRNAs were down-regulated (P311, JUN, IGF-1-BP5).
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Following this initial analysis, we further examined whether disuse atrophy induced by either denervation or spinal isolation elicited a similar transcriptional response as seen during the systemic atrophy states. Although there were many changes unique to disuse atrophy (~280 genes -most associated with the neuromuscular junction), 70% of the originally identified "atrogenes" were similarly induced or suppressed following disuse during the phase of rapid atrophy. However, with time after denervation or disuse, these atrophy-related changes in gene expression were no longer evident. Thus, different types of muscle atrophy share a common transcriptional program, which is activated in many systemic diseases or with disuse.
